interestingly, the current human cDC transcriptome data has indicated the upregulation of genes associated with defined Fc receptors; OSCAR and FCGR2A (Table 1), which might support our hypothesis that ADCC might be an alternate mechanism by which the rASP-1 adjuvant exerts it potency after primary immunization when used with the influenza vaccine. The gene discussed is FCGR2A; the disease is influenza.